Levodopa and malignant melanoma.
D004295:Dihydroxyphenylalanine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008545:Melanoma / Q000139:chemically induced*; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000139:chemically induced*
D004295:Dihydroxyphenylalanine